COVID-19 Emergency Ventilator

In response to the COVID-19 outbreak, Imperial’s experts in medical device design (bioengineering) – and a clinician treating infected patients – have designed an emergency ventilator that can be built to meet MHRA and FDA requirements using generic parts.  JAMVENT provides a simple, low-cost solution to ventilator shortages worldwide, particularly for health services in developing countries. Plus the robust design also makes it suitable for long term use beyond current COVID-19 needs.

The design document for the JAMVENT ventilator can be requested by those wishing to develop ventilators for their local healthcare providers and includes a list of parts and a software spec.

We welcome enquiries from health organisations, manufacturers and donors interested in working with us to take JAMVENT from design to manufacture.

 

Design benefits

  • Long term use – not specific to the COVID-19 crisis
  • Easy to manufacture from low cost components (estimated at around £1,500 in the UK)
  • Does not require specific pressure transducers or solenoids
  • Parts can be sourced from various manufacturers – avoiding supply-chain bottlenecks
  • No specialist or medical supply chain components – and no balloons
  • Simple electronics
  • Doesn’t require gas to drive it – unlike some others – which is critical where gas supply is limited.
  • Employs fluid mechanical design principles

 

Ventilator design meets clinicians needs

  • PEEP controllable electronically
  • Pressure Regulated Volume Control (PRVC) mode
  • Supports spontaneous breath
  • Maintains PEEP during suctioning

Performance evidence

Evidence that the JAMVENT prototype can perform to MHRA and ISO 80601 tests can be downloaded here.

It also highlights PRVC and spontaneous mode performance and how it can maintain PEEP during suctioning – critical functions of ICU ventilators for COVID-19 patients.

 

JAMVENT ventilator in action – click to view a video

 

Ventilator system

 


Creators of the emergency ventilator design

  • Project and Technical Lead – Dr Joseph Sherwood – RAEng Research Fellow, Department of Bioengineering. Research areas include biofluid mechanics, flow measurement/control, device design for research.
  • Clinical Lead – Dr. Jakob Mathiszig-Lee – Honorary Research Fellow and Senior Anaesthetic Registrar at the Royal Brompton Hospital. Department of Surgery and Cancer.
  • Project Manager – Prof James Moore – The Bagrit Chair in Medical Device Design, Department of Bioengineering. Research areas include biofluid mechanics, cardiovascular device design, device translation.
  • Co-Technical Lead – Dr Michael Madekurozwa, Department of Bioengineering. Research areas include experimental biofluid dynamics, design and implementation of tools, hardware and software for use in research.

Who to contact:

Anne Freitag

Anne Freitag

Engagement Manager

For Materials, Bioengineering, Chemical Engineering, Computing, Earth Sciences, Cyber Security, Data Science, AI, 

Tel: +44 (0)20 7594 6572

Email me

All areas of expertise:

Related Insights

Healthcare AI

Healthcare AI

AI not only automates problem-solving carried out by doctors, but can also make quicker and better decision and apply problem-solving techniques that humans alone could not. read more

Digital transformation

Digital transformation

Some think of business as usual, replacing physical tasks with digital alternatives. Others envisage a more profound change, with new products or services made possible by digital technologies. read more

Pandemics and privacy

Pandemics and privacy

Contact tracing apps will take and keep some data from users. This insight discusses ways of minimising privacy implications. read more

Related case studies

Virtual worlds for real-life problems

Virtual worlds for real-life problems

Our consultants shared their expertise in new media applications in healthcare to help introduce the Memorial Sloan-Kettering Cancer Center chemotherapy clinic staff and patients to a virtual world equivalent using the open source Second Life application. read more

Management of pests and vectors of disease

Management of pests and vectors of disease

Helping small-holder farmers with cost-effective techniques to manage pests and vectors of disease, reducing the use of chemical pesticides and promoting the efficiency of natural processes. read more

Neuropathic pain drug development

Neuropathic pain drug development

Our consultants shared their expertise in neuropathic pain area treatments to support Spinifex’s drug discovery and development programs. read more

Latest news

Heinz to adopt Coca Cola’s sustainable PlantBottle® packaging

Heinz to adopt Coca Cola’s sustainable PlantBottle® packaging

Heinz has announced a strategic partnership enabling them to use Coca Cola’s PlantBottle® packaging. A project through Imperial Consultants (ICON) demonstrated that this plant based packaging reduces CO2 impact by 12-19%. read more

Imperial’s experts to help clean-tech startups

Imperial’s experts to help clean-tech startups

Mayor of London Sadiq Khan announced the launch of Better Futures - an incubator focused on clean-tech startups to be led by Sustainable Bridges and delivered by the GLA, Imperial College London, Imperial Consultants and OPDC (Old Oak and Park Royal Development Corporation). read more

New freshwater control system may resolve flood challenges

New freshwater control system may resolve flood challenges

A new river control system that uses smart technology has been shown to reduce downstream flooding, in a consultancy project carried out by Dr Wouter Buytaert for PyTerra. read more